Supplemental material for ADC quantification to classify patients candidate to receive bevacizumab treatment for recurrent glioblastoma

Asenjo García, Beatriz; Navarro Guirado, Félix; Nagib Raya, Fátima; Vidal Denis, María; Bravo Rodríguez, Francisco; Galán Montenegro, Pedro

doi:10.25384/SAGE.9167210.v1

Supplemental_Material.pdf (76.49 kB)

Supplemental material for ADC quantification to classify patients candidate to receive bevacizumab treatment for recurrent glioblastoma

journal contribution

posted on 2019-07-30, 12:18 authored by Beatriz Asenjo García, Félix Navarro Guirado, Fátima Nagib Raya, María Vidal Denis, Francisco Bravo Rodríguez, Pedro Galán Montenegro

Supplemental Material for ADC quantification to classify patients candidate to receive bevacizumab treatment for recurrent glioblastoma by Beatriz Asenjo García, Félix Navarro Guirado, Fátima Nagib Raya, María Vidal Denis, Francisco Bravo Rodríguez and Pedro Galán Montenegro in Acta Radiologica